THIO Sequenced With Cemiplimab in Advanced NSCLC

PHASE2RecruitingINTERVENTIONAL
Enrollment

227

Participants

Timeline

Start Date

June 8, 2022

Primary Completion Date

June 30, 2026

Study Completion Date

December 31, 2026

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

6-Thio-2'-Deoxyguanosine

small molecule telomere targeting agent

DRUG

Cemiplimab

programmed cell death protein 1 (PD-1) inhibitor

Trial Locations (33)

98

ACTIVE_NOT_RECRUITING

Debreceni Egyetem Klinikai Kozpont, Tudogyogyaszati Klinika, Debrecen

114

RECRUITING

Tri-Service General Hospital, Taipei

333

RECRUITING

Chang-Gung Memorial Hospital - Linko, Taoyuan

833

RECRUITING

Chang-Gung Memorial Hospital, Kaohsiung City

1784

SUSPENDED

MC Synexus Sofia EOOD, Sofia

3065

SUSPENDED

St. Vincent Hospital Melbourne, Fitzroy

4556

SUSPENDED

Sunshine Coast Haematology and Oncology Clinic, Buderim

5000

SUSPENDED

Cancer Research SA, Adelaide

5800

SUSPENDED

"MHAT HEART AND BRAIN EAD Clinic of Medical Oncology", Pleven

6000

ACTIVE_NOT_RECRUITING

Bács-Kiskun Megyei Oktatókórház, Onkoradiológiai Központ, Kecskemét

11031

RECRUITING

Taipei Medical University Hospital, Taipei

11214

RECRUITING

Taipei Veterans General Hospital, Taipei

23142

RECRUITING

Taipei Tzu Chi Hospital, New Taipei City

Unknown

SUSPENDED

"MHAT Serdika EOOD", Sofia

SUSPENDED

"UMHAT Sofiamed", Sofia

RECRUITING

National Taiwan University Hospital, Taipei

RECRUITING

Liv Hospital Ankara, Medikal Onkoloji Bilim Dalı, Ankara

RECRUITING

İstinye Üniversitesi Hastanesi Liv Hospital Bahçeşehir, Istanbul

25-29

NOT_YET_RECRUITING

Semmelweis Egyetem Pulmonologiai Klinika, Budapest

u. 1.

ACTIVE_NOT_RECRUITING

Országos Korányi Pulmonológiai Intézet, Budapest

u. 7-9

ACTIVE_NOT_RECRUITING

Orszagos Onkologiai Intezet, Budapest

HRSZ7151

ACTIVE_NOT_RECRUITING

Mátrai Gyógyintézet, Mátraháza

u 21

ACTIVE_NOT_RECRUITING

Hetenyi Geza Korhaz, Onkologiai Kozpont, Szolnok

70. 2045

ACTIVE_NOT_RECRUITING

Tüdőgyógyintézet Törökbálint, Onkológiai Osztályc, Törökbálint

32-600

ACTIVE_NOT_RECRUITING

NZOZ FORMED 2 Sp. z o.o., Oświęcim

85-796

ACTIVE_NOT_RECRUITING

Centrum Onkologii im. prof. F. Lukaszczyka, Bydgoszcz

31-202

ACTIVE_NOT_RECRUITING

Krakowski Szpital Specjalistyczny im. Jana Pawla II Oddzial Onkologii z Pododdzialem Diagnostyki Nowotworow Klatki Piersiowej, Krakow

90-338

ACTIVE_NOT_RECRUITING

Centrum Terapii Współczesnej J. M. Jasnorzewska, Lodz

20-064

ACTIVE_NOT_RECRUITING

NeuroMed, Lublin

60-693

ACTIVE_NOT_RECRUITING

Med Polonia Sp z o.o., Poznan

35-021

ACTIVE_NOT_RECRUITING

Centrum Medyczne Mrukmed, Rzeszów

60-185

ACTIVE_NOT_RECRUITING

Centrum Medyczne Pratia, Skorzewo

87-100

ACTIVE_NOT_RECRUITING

Wojewodzki Szpital Zespolony im. L. Rydygiera w Toruniu, Oddzial Chemioterapii Nowotworow, Torun

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Maia Biotechnology

INDUSTRY

NCT05208944 - THIO Sequenced With Cemiplimab in Advanced NSCLC | Biotech Hunter | Biotech Hunter